U.S. Stocks Open Higher After Promising Vaccine Study
July 15 2020 - 10:02AM
Dow Jones News
By Joe Wallace
U.S. stocks rose Wednesday as investors cheered promising
results from the study of an experimental coronavirus vaccine while
reviewing earnings from more of the nation's biggest financial
companies.
The S&P 500 advanced 1.1%, signaling a second day of gains
for the benchmark index. The Dow Jones Industrial Average added 362
points, or 1.3%, while the Nasdaq Composite Index rose 0.7%.
European stocks also jumped, led by travel-and-leisure
companies. Shares fell in China after President Trump signed into
law a sanctions bill to punish Chinese officials over Beijing's
crackdown on Hong Kong.
Investor sentiment was lifted by new details released late
Tuesday about the first human study of Moderna's vaccine. The
results showed that the vaccine induced the desired immune response
for all 45 people evaluated. Researchers said the study reinforced
their decision to take the shot into a large, decisive clinical
trial scheduled to start in late July.
Shares of Moderna shot up 15% in early trading.
"Every time we get some sort of positive news on the vaccine
front, then understandably markets benefit from that," said Paul
Jackson, head of asset-allocation research at Invesco. "The way
it's looking at the moment, it really looks as though a vaccine is
the only hope. This thing is not going away."
Dr. Anthony Fauci, the government's top infectious-disease
expert, said the large study could yield an answer by year-end
about whether the vaccine induced immune responses sufficient to
protect people safely from Covid-19. A positive answer would clear
the way for wider use and potentially help curb the pandemic.
Coronavirus infections and deaths continued to climb in the U.S.
Tuesday, with several states hitting records. Florida reported 132
new coronavirus-related deaths, its highest single-day tally since
the pandemic began, and 9,194 new cases.
Ahead of the opening bell in New York, shares in Goldman Sachs
Group gained 5.9% after the bank's quarterly profit held steady
from a year ago. Goldman's results bucked those of larger
commercial lenders that saw earnings plummet as the coronavirus
tore through the U.S. economy.
Shares in U.S. Bancorp rose 4.2% premarket after the bank
reported second-quarter earnings that beat analyst
expectations.
Shares in Apple climbed 1.4% premarket after the tech company
won a major legal battle with the European Union. The bloc's
second-highest court sided with the U.S. company over a EUR13
billion ($14.8 billion) tax bill that EU antitrust officials had
said the U.S. company owed to Ireland.
Meanwhile, U.S. industrial production continued to recover in
June, the Federal Reserve said. Production rose 5.4%, accelerating
from the 1.4% growth recorded in May.
Overseas, the Stoxx Europe 600 rose 1.7%, with gains for airline
and cruise-line stocks. China's Shanghai Composite Index fell 1.6%
and Hong Kong's Hang Seng closed largely flat after Mr. Trump
signed the bipartisan sanctions bill into law.
The legislation requires sanctions targeting Chinese officials
who crack down on the rights of Hong Kong residents to free speech
and peaceful assembly, as well as the banks that do business with
those officials. The president also said he had signed an executive
order that would end preferential treatment for Hong Kong, a blow
to its status as a financial center.
Oil prices fell as a committee at the Organization of the
Petroleum Exporting Countries met to debate the group's current and
future production. Brent-crude futures slipped 0.2% to $42.82 a
barrel, reversing earlier gains.
In a sign of the upbeat mood among investors, the yield on
10-year Treasury notes rose to 0.650%, from 0.614% Tuesday. The WSJ
Dollar Index, which tracks the dollar against a basket of other
currencies, slipped 0.4%.
Write to Joe Wallace at Joe.Wallace@wsj.com
(END) Dow Jones Newswires
July 15, 2020 09:47 ET (13:47 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.